LOLeticia Alves de Oliveira

Leticia Alves de Oliveira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Leticia Alves de Oliveira has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical, radiological and immunohistological distinctions between limbic-predominant and typical Alzheimer’s disease: A systematic review

    by Guilherme Linha Secco, Lucas Ribas Lachman, Leticia Alves de Oliveira, Maisa Baldinu Caramujo, Lunna Giovanna Gonçalves Campos, Alana Barroso de Carvalho, Giovanna Moreira Nascimento de Castro, Fábio Henrique Malinoski, Caroline de Oliveira Christoff, Mateus Cordeiro Merlim da Silva

    Background: Alzheimer’s disease (AD) is the leading cause of dementia worldwide, with prominent hippocampal and medial temporal lobe atrophy. Limbic-predominant (LP) AD has been proposed as a distinct subtype, but distinctions from typical AD remain unclear. This systematic review evaluates clinical, radiological, and immunohistological differences between LP and typical AD. Methods: Following PRISMA guidelines, PubMed, Embase, and Web of Science were searched. Data on baseline characteristics, clinical, radiological, and immunohistological features were extracted. Screening was performed with Rayyan.ai, and study quality was assessed using the Newcastle–Ottawa Scale. Results: From 211 articles, 21 studies were included, totaling 11,315 patients: 1,178 (15.7%) LP, 4,159 (36.7%) typical AD, and 5,378 (47.6%) other presentations. Weighted averages: education 24.31 years (LP) vs. 17.15 years (AD); age at onset 77.36 years (LP) vs. 72.33 years (AD); disease duration 8.43 years (LP) vs. 8.95 years (AD). Clinical presentations were similar, with cognitive impairment and memory deficits predominant. MRI and FDG-PET revealed lower hippocampal volume and higher metabolism in LP. Tau-PET showed lower R2 relaxation in parietal, cingulate, and cuneus regions and elevated hippocampal neurofibrillary tangles. Immunohistology revealed higher hippocampal tau burden and more TDP-43 inclusions in LP compared to typical AD. Conclusion: LP and typical AD exhibit notable radiological and immunohistological differences, though clinical presentations overlap. Current evidence cannot definitively classify LP as a distinct subtype or separate disease. Further studies are required to clarify these distinctions.

  • Open Access

    Uso de metilfenidato entre médicos residentes de Paraná

    by Julia Schuster Dalacorte, Leticia Alves de Oliveira, Roberta Rafaelle Dalzotto, Gabriella Cristina Chicalski, Felício de Freitas Netto, Tatiana Menezes Garcia Cordeiro

    Resumen El programa de residencia médica se caracteriza por una intensa carga horaria y una alta exigencia, lo que favorece el uso de sustancias para mantener el rendimiento cognitivo. Este estudio transversal y cuantitativo investigó la prevalencia y las repercusiones del uso de metilfenidato entre médicos en el primer año de residencia en Paraná. 81 residentes (6,37% de la población estimada) respondieron un cuestionario en línea que abordaba datos sociodemográficos, el uso y los efectos del clorhidrato de metilfenidato y la escala DASS-21. La prevalencia de uso fue del 25,9%, siendo los principales motivos: aumento de la concentración (66,7%) y reducción del cansancio (38,1%). Entre los efectos adversos, destacaron la taquicardia (52,4%) y la ansiedad (38,1%). Se observó una asociación significativa entre el uso de metilfenidato y mayores niveles de estrés (p=0,009). El uso de estimulantes mostró beneficios subjetivos, pero se asoció con un impacto negativo en la salud mental, lo que indica la necesidad de acciones educativas e institucionales que desincentiven su uso no médico.

  • Open Access

    Uso de metilfenidato entre médicos residentes do Paraná

    by Julia Schuster Dalacorte, Leticia Alves de Oliveira, Roberta Rafaelle Dalzotto, Gabriella Cristina Chicalski, Felício de Freitas Netto, Tatiana Menezes Garcia Cordeiro

    Resumo O programa de residência médica é caracterizado por intensa carga horária e alta exigência, favorecendo o uso de substâncias para sustentação do desempenho cognitivo. Este estudo transversal e quantitativo investigou a prevalência e as repercussões do uso de metilfenidato entre médicos no primeiro ano de residência no Paraná. Oitenta e um residentes (6,37% da população estimada) responderam a questionário on-line que abordava dados sociodemográficos, uso e efeitos do cloridrato de metilfenidato e a escala DASS-21. A prevalência de uso foi de 25,9%, sendo os principais motivos: aumento da concentração (66,7%) e redução do cansaço (38,1%). Entre os efeitos adversos, destacaram-se taquicardia (52,4%) e ansiedade (38,1%). Houve associação significativa entre uso de metilfenidato e maiores níveis de estresse (p=0,009). O uso de estimulantes mostrou benefícios subjetivos, mas se associou a impacto negativo sobre a saúde mental, indicando a necessidade de ações educativas e institucionais que desestimulem seu uso não médico.

  • Open Access

    Use of methylphenidate among medical residents in Paraná

    by Julia Schuster Dalacorte, Leticia Alves de Oliveira, Roberta Rafaelle Dalzotto, Gabriella Cristina Chicalski, Felício de Freitas Netto, Tatiana Menezes Garcia Cordeiro

    Medical residency programs are characterized by intense workloads and high demands, favoring the use of substances to sustain cognitive performance. This cross-sectional and quantitative study investigated the prevalence and repercussions of methylphenidate use among first-year medical residents in Paraná. 81 residents (6.37% of the estimated population) responded to an online questionnaire addressing sociodemographic data, the use and effects of methylphenidate hydrochloride, and the DASS-21 scale. The prevalence of use was 25.9%, with the main objectives being to increase concentration (66.7%) and to reduce fatigue (38.1%). Among the adverse effects, tachycardia (52.4%) and anxiety (38.1%) stood out. A significant association was found between methylphenidate use and higher stress levels (p=0.009). The use of stimulants showed subjective benefits but was also associated with negative impacts on mental health, indicating the need for educational and institutional actions to discourage its non-medical use.